Posted inBiotechnology
Biogen’s litifilimab sparkles in midphase lupus trial, raising hopes for pivotal readout
Biogen’s lupus drug candidate litifilimab has improved outcomes in another phase 2 trial, adding to the momentum behind a program barreling…









